亚太地区 GMP 细胞治疗耗材市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品(试剂盒、试剂/分子生物学试剂、生长因子/细胞因子和白细胞介素等)、细胞治疗(NK 细胞)治疗、干细胞治疗、T 细胞治疗等)、流程(细胞收集和表征/分选和分离、细胞培养和扩增/制备、冷冻保存、细胞加工和配制、细胞分离和激活、细胞分配/处理、过程监测和控制/重新管理/质量保证等)和最终用途(临床、商业和研究)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 168    |    Report Code: BMIRE00027802    |    Category: Life Sciences

Asia Pacific GMP Cell Therapy Consumables Market

亚太地区GMP细胞治疗耗材市场预计将从2022年的191,828万美元增长到2028年的9,093.86百万美元;预计 2022 年至 2028 年复合年增长率为 29.6%。

 

战略合作增加推动亚太GMP细胞治疗耗材市场

亚太GMP细胞治疗耗材市场的公司正在就新产品和细胞的开发进行战略合作疗法治疗。以下是 GMP 细胞治疗耗材市场的一些战略合作:

  • 2022 年 10 月,Pluristyx、panCELLa 和 Implant Therapeutics 管理层宣布公司合并,待批准股东批准。合并后的公司将整合互补的产品组合,提供端到端的客户支持,并提供更多的诱导多能干细胞 (iPSC) 相关产品和服务。集成的技术和服务产品将加速革命性细胞疗法的开发和向患者提供。
  • 2022 年 6 月,CellPoint 和 AboundBio 与 Galapagos 达成最终协议,推动 Galapagos 进入下一代细胞疗法,同时显着扩大其产品组合和能力。该协议的目的是扩大当前的 CAR-T 疗法市场,并对需要额外和改进治疗选择的患者产生重要影响。
  • 2021 年 11 月,Laurus Labs与先进细胞和基因治疗公司Immunoadoptive Cell Therapy Private Limited (ImmunoACT)签署投资协议,在满足一定条件的前提下,以4.66美元收购26.62%股权(完全稀释基础上)。

因此,市场参与者之间越来越多的细胞治疗开发战略合作推动了 GMP 细胞治疗耗材的使用,以实现所需的产品,从而推动了增长亚太 GMP 细胞治疗耗材市场概况。

 

亚太 GMP 细胞治疗耗材市场概况

 

亚太地区 GMP 细胞治疗耗材市场分为中国、日本、印度、韩国、澳大利亚、韩国和其他地区亚太地区。亚太地区 GMP 细胞治疗耗材市场的增长归因于制药行业的不断发展、该地区参与者数量的不断增加、法规的增多以及对细胞治疗的认识不断提高。中国是全球第一个批准细胞治疗的国家基因治疗于2003年问世。然而,由于缺乏明确和严格的监管框架,细胞和基因治疗(CGT)的发展被推迟。 CGT在全球的快速发展及其治疗潜力促使政府进行监管改革,以促进CGT在中国的规范发展。 2017年,有关细胞治疗的法规发生了变化,所有细胞治疗类别的产品都蓬勃发展。根据 Nature 进行的研究,截至 2021 年 3 月,大约启动了 953 项细胞和基因治疗临床试验,包括研究性新药 (IND)、注册试验和研究者发起的试验 (IIT)。在政策支持的推动下,中国企业资本利税近年来取得了显着进展,成为企业资本利税发展的领先国家。

 

亚太地区 GMP 细胞治疗耗材市场收入及 2028 年预测(百万美元)

亚太地区 GMP 细胞治疗耗材市场细分

  ;

亚太地区 GMP 细胞治疗耗材市场根据产品、细胞治疗、工艺、最终用途和国家/地区进行细分。

 

  • 根据产品,GMP细胞治疗耗材市场分为试剂盒、试剂/分子生物学试剂、生长因子/细胞因子和白细胞介素(包括蛋白质和核酸纯化缓冲液)等。 2022年,试剂盒细分市场占据最大市场份额。
  • 以细胞治疗为基础,对GMP细胞治疗耗材市场进行细分NK细胞疗法、干细胞疗法、T细胞疗法等。 T 细胞疗法细分市场在 2022 年占据最大市场份额。
  • 基于工艺,亚太地区 GMP 细胞疗法耗材市场细分为细胞收集和表征/分选和分离、细胞培养和扩增/制备、冷冻保存、细胞处理和配制、细胞分离和激活、细胞分配/处理、过程监测和控制/重新管理/质量保证,以及其他的。 2022 年,细胞收集和表征/分选和分离领域占据了最大的市场份额。
  • 根据最终用途,亚太地区 GMP 细胞治疗耗材市场分为临床、商业和研究。 2022 年,临床细分市场占据最大市场份额。
  • 按国家/地区划分,亚太地区 GMP 细胞治疗耗材市场细分为澳大利亚、中国、印度、日本、韩国和亚太其他地区。中国在 2022 年占据市场主导地位。

Bio-Techne Corp、BPS Bioscience Inc、Corning Inc、FUJIFILM Irvine Scientific Inc、Global Life Sciences Solutions USA LLC、Lonza Group AG、Merck KGaA、Miltenyi Biotec BV 和Co KG、Sartorius AG 和 Thermo Fisher Scientific Inc 是亚太 GMP 细胞治疗耗材市场的领先公司。



Asia Pacific GMP Cell Therapy Consumables Strategic Insights

Strategic insights for Asia Pacific GMP Cell Therapy Consumables involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-gmp-cell-therapy-consumables-market-strategic-framework.webp
Get more information on this report

Asia Pacific GMP Cell Therapy Consumables Report Scope

Report Attribute Details
Market size in 2022 US$ 1,918.28 Million
Market Size by 2028 US$ 9,093.86 Million
Global CAGR (2022 - 2028) 29.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 试剂盒
  • 试剂/分子生物学试剂
  • 生长因子/细胞因子
  • 白细胞介素
By 细胞疗法
  • NK细胞疗法
  • 干细胞疗法
  • T细胞疗法
By 过程
  • 细胞收集和表征/分选和分离
  • 细胞培养和扩增/制备
  • 低温保存
  • 细胞处理和配制
  • 细胞分离和激活
  • 细胞分布/处理
  • 过程监控
  • 控制/重新管理/质量保证
By 最终用途
  • 临床
  • 商业
  • 研究
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Bio-Techne Corp
  • BPS Bioscience Inc
  • Corning Inc
  • FUJIFILM Irvine Scientific Inc
  • Global Life Sciences Solutions USA LLC
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec BV & Co KG
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Get more information on this report

    Asia Pacific GMP Cell Therapy Consumables Regional Insights

    The regional scope of Asia Pacific GMP Cell Therapy Consumables refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-gmp-cell-therapy-consumables-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific GMP Cell Therapy Consumables Market

    1. Bio-Techne Corp
    2. BPS Bioscience Inc
    3. Corning Inc
    4. FUJIFILM Irvine Scientific Inc
    5. Global Life Sciences Solutions USA LLC
    6. Lonza Group AG
    7. Merck KGaA
    8. Miltenyi Biotec BV & Co KG
    9. Sartorius AG
    10. Thermo Fisher Scientific Inc
    Frequently Asked Questions
    How big is the Asia Pacific GMP Cell Therapy Consumables Market?

    The Asia Pacific GMP Cell Therapy Consumables Market is valued at US$ 1,918.28 Million in 2022, it is projected to reach US$ 9,093.86 Million by 2028.

    What is the CAGR for Asia Pacific GMP Cell Therapy Consumables Market by (2022 - 2028)?

    As per our report Asia Pacific GMP Cell Therapy Consumables Market, the market size is valued at US$ 1,918.28 Million in 2022, projecting it to reach US$ 9,093.86 Million by 2028. This translates to a CAGR of approximately 29.6% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific GMP Cell Therapy Consumables Market report typically cover these key segments-

  • 产品 (试剂盒, 试剂/分子生物学试剂, 生长因子/细胞因子, 白细胞介素)
  • 细胞疗法 (NK细胞疗法, 干细胞疗法, T细胞疗法)
  • 过程 (细胞收集和表征/分选和分离, 细胞培养和扩增/制备, 低温保存, 细胞处理和配制, 细胞分离和激活, 细胞分布/处理, 过程监控, 控制/重新管理/质量保证)
  • What is the historic period, base year, and forecast period taken for Asia Pacific GMP Cell Therapy Consumables Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific GMP Cell Therapy Consumables Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific GMP Cell Therapy Consumables Market?

    The Asia Pacific GMP Cell Therapy Consumables Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bio-Techne Corp
  • BPS Bioscience Inc
  • Corning Inc
  • FUJIFILM Irvine Scientific Inc
  • Global Life Sciences Solutions USA LLC
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec BV & Co KG
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The Asia Pacific GMP Cell Therapy Consumables Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific GMP Cell Therapy Consumables Market value chain can benefit from the information contained in a comprehensive market report.